KEMPHARM, INC

Profile

Company Names

KEMPHARM, INC
KEMPHARM INC

Addresses

1180 CELEBRATION BOULEVARD, SUITE 103, CELEBRATION, FL 34747

2656 CROSSPARK ROAD, SUITE 100, CORALVILLE, IA 52241

7 HAWKEYE DRIVE, SUITE 103, NORTH LIBERTY, IA 52317

7 HAWKEYE DRIVE, SUITE 103, NORTH LIBERTY, IA 52317

Phone Numbers

321-939-3416
319-665-2575

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2006

State Incorporated:

IA

Total Amount Raised:

$205,309,651.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2021-06-18 
$39,098,530.00 
$39,098,530.00 
$0.00 
 
9
2021-01-26 
$44,025,381.00 
$44,025,381.00 
$0.00 
 
8
2021-01-12 
$31,476,984.00 
$31,476,984.00 
$0.00 
Equity 
7
2020-01-13 
$3,037,354.00 
$3,037,354.00 
$0.00 
 
6
2019-12-18 
$71,418,011.00 
$71,418,011.00 
$0.00 
 
5
2018-10-25 
$1,150,000.00 
$1,150,000.00 
$0.00 
 
4
2015-02-19 
$4,000,000.00 
$4,000,000.00 
$0.00 
Equity 
3
2013-05-17 
$762,000.00 
$9,000,000.00 
$8,238,000.00 
Debt 
2
2010-07-22 
$6,852,006.00 
$25,000,000.00 
$18,147,994.00 
Equity 
1
2009-04-27 
$3,489,385.00 
$3,856,400.00 
$367,015.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
R. 
LADUANE 
CLIFTON 
EXECUTIVE OFFICER
TODD 
 
DOORENBOS 
DIRECTOR
SVEN 
 
GUENTHER 
EXECUTIVE OFFICER, DIRECTOR
KATHLEEN 
H. 
HOLT 
EXECUTIVE OFFICER
GORDON 
K. 
JOHNSON 
EXECUTIVE OFFICER
TODD 
J. 
JOHNSON 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
 
KARR 
EXECUTIVE OFFICER, DIRECTOR
KARLTON 
 
KLEIS 
DIRECTOR
CHRISTOPHER 
 
LAUDERBACK 
EXECUTIVE OFFICER
JONATHAN 
S. 
LEFF 
DIRECTOR
CHRISTAL 
 
MICKLE 
EXECUTIVE OFFICER, DIRECTOR
CHRISTAL 
M. M. 
MICKLE 
EXECUTIVE OFFICER, DIRECTOR
CHRISTAL 
M.M. 
MICKLE 
EXECUTIVE OFFICER, DIRECTOR
TRAVIS 
 
MICKLE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
TRAVIS 
C. 
MICKLE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
RICHARD 
W. 
PASCOE 
DIRECTOR
MATT 
 
PLOOSTER 
DIRECTOR
MATTHEW 
 
PLOOSTER 
DIRECTOR
MATTHEW 
R. 
PLOOSTER 
DIRECTOR
JOSEPH 
B. 
SALURI 
DIRECTOR
TIMOTHY 
J. 
SANGIOVANNI 
EXECUTIVE OFFICER
DAN 
 
THOMPSON 
DIRECTOR
DANNY 
 
THOMPSON 
DIRECTOR
DANNY 
L. 
THOMPSON 
DIRECTOR
DAVID 
S. 
TIERNEY 
DIRECTOR
TRACY 
M. 
WOODY 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2021-06-18 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2021-01-26 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-01-12 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-01-13 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2019-12-18 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2018-10-25 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-02-19 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2013-05-17 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-07-22 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-04-27 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-04-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
ROTH CAPITAL PARTNERS, LLC
NONE
NONE
COWEN + COMPANY, LLC
DEWAAY FINANCIAL NETWORK, LLC
ADAM STONE CLAYPOOL